Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nyin oi medical product trading - pteria martensii; lonicera japonica; forsythia suspensa; schizonepeta tenuifolia; saposhnikovia divaricata; citri rubrum; fritillaria cirrhosa; notopterygium incisum; angelica dahurica; pogostemon cablin; pinellia ternata; glycyrrhiza uralensis; peucedanum praeruptorum -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nyin oi medical product trading - uncaria rhynchophylla; pinellia ternata; pogostemon cablin; pteria martensii; gastrodia elata; mentha haplocalyx; citri grandis; poria cocos; fritillaria cirrhosa; notopterygium incisum; peucedanum praeruptorum; glycyrrhiza uralensis -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nyin oi medical product trading - spatholobus suberectus; salvia miltiorrhiza; lycium barbarum; panax notoginseng; citrus reticulata; ophiopogon japonicus; curcuma wenyujin; panax ginseng; paeoniae rubra; acorus tatarinowii; carthamus tinctorius; ligusticum chuanxiong; prunus persica -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nyin oi medical product trading - areca catechu; lonicera japonica; sophora japonica; coptis chinensis; angelica sinensis; carthamus tinctorius; boswellia carterii; paeoniae rubra; saposhnikovia divaricata; angelica dahurica; commiphora myrrha; glycyrrhiza uralensis -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nyin oi medical product trading - rhizoma pinellia ternata thunb.; rhizoma gastrodia elata.; radix saposhnikovia divaricata; pteria martensii (dunker); pericarpium citrus reticulata.; radix platycodon grandiflorum; bulbus fritillaria cirrhosa; herba mentha haplocalyx -

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - procarbazine hydrochloride, quantity: 58.3 mg (equivalent: procarbazine, qty 50 mg) - capsule, hard - excipient ingredients: gelatin; iron oxide yellow; magnesium stearate; titanium dioxide; purified talc; mannitol; maize starch - indications as at 23 august 1991: treatment of hodgkin's disease (multiple lymphadenoma); treatment of other malignant lymphomas including lymphosarcoma, reticulosarcoma, brill-symmers disease. natulan is dissimilar to other cytostatic agents and may be effective in cases resistant to other drugs and x-rays.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - procarbazine hydrochloride, quantity: 58.3 mg (equivalent: procarbazine, qty 50 mg) - capsule, hard - excipient ingredients: gelatin; iron oxide yellow; magnesium stearate; titanium dioxide; purified talc; mannitol; maize starch - indications as at 23 august 1991: treatment of hodgkin's disease (multiple lymphadenoma); treatment of other malignant lymphomas including lymphosarcoma, reticulosarcoma, brill-symmers disease. natulan is dissimilar to other cytostatic agents and may be effective in cases resistant to other drugs and x-rays.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - dapsone, quantity: 100 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; silicon dioxide; microcrystalline cellulose - dermatitis herpetiformis. leprosy. actinomycotic mycetoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - dapsone, quantity: 25 mg - tablet, uncoated - excipient ingredients: silicon dioxide; magnesium stearate; microcrystalline cellulose; maize starch - dermatitis herpetiformis. leprosy. actinomycotic mycetoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - erythromycin lactobionate, quantity: 1.4882 g/g (equivalent: erythromycin, qty 1 g) - injection, powder for - excipient ingredients: - oral erythromycin is not considered to be the antibiotic of choice in severely ill patients.,erythromycin-link (sterile erythromycin lactobionate) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. intravenous therapy should be replaced by oral administration at the appropriate time.,? upper respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae); haemophilus influenzae (many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved).,? lower respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae).,? respiratory tract infections due to mycoplasma pneumoniae.,? skin and s